+499.5%
MRNA vs VEU
+28.8%
+470.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VEU | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.5% | -2.8% | -3.2% |
| 7D | +5.5% | +1.1% | +4.3% | +3.2% |
| 30D | +158.7% | +2.2% | +156.6% | +151.8% |
| 3M | +182.1% | +3.0% | +179.1% | +171.0% |
| 6M | +151.8% | +10.9% | +141.0% | +120.4% |
| YTD | +393.6% | +18.2% | +375.4% | +275.0% |
| 1Y | +499.5% | +28.3% | +471.2% | +244.8% |
| All | +499.5% | +28.8% | +470.6% | +244.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VEU.
Daily Out/Under-Performance
Portfolio return minus VEU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling